<DOC>
	<DOCNO>NCT02985684</DOCNO>
	<brief_summary>Evaluate safety efficacy GORE® CARDIOFORM ASD Occluder percutaneous closure ostium secundum atrial septal defect ( ASDs )</brief_summary>
	<brief_title>Safety Efficacy Study Transcatheter Closure Ostium Secundum ASDs</brief_title>
	<detailed_description>This prospective , multicenter , single-arm clinical study compare outcome GORE® CARDIOFORM ASD Occluder performance goal derive clinical investigation outcome device indicate ASD closure .</detailed_description>
	<mesh_term>Heart Septal Defects</mesh_term>
	<mesh_term>Heart Septal Defects , Atrial</mesh_term>
	<criteria>Appropriate ASD anatomy Note : Additional Inclusion Criteria may apply Absence concurrent cardiac condition could elevate morbidity/mortality beyond common ASD Note : Additional Exclusion Criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>